Chuang Lin
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Angiogenesis and VEGF in Cancer 1
- Histone Deacetylase Inhibitors Research 1
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Liang Zhao (6 shared papers)Rui Zhou (3 shared papers)Kehong Zheng (3 shared papers)Shibin Yang (2 shared papers)Hui Wang (1 shared paper)Xin Li (1 shared paper)Weidong Li (1 shared paper)Mingxin Pan (1 shared paper)
- Journals
- Oncogene (2 papers)Cell Death and Disease (2 papers)Cell Reports (1 paper)Diagnostic Pathology (1 paper)EBioMedicine (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Chuang Lin
12 papers receiving 427 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 128
- Molecular Biology 221
- Oncology 69
- Cell Biology 32
- Immunology 36
Countries citing papers authored by Chuang Lin
This map shows the geographic impact of Chuang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuang Lin more than expected).
Fields of papers citing papers by Chuang Lin
This network shows the impact of papers produced by Chuang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuang Lin. The network helps show where Chuang Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chuang Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 121 | |
| 2 | 2019 | 70 | |
| 3 | 2020 | 58 | |
| 4 | 2021 | 44 | |
| 5 | 2020 | 39 | |
| 6 | 2018 | 30 | |
| 7 | 2019 | 25 | |
| 8 | 2020 | 22 | |
| 9 | 2014 | 12 | |
| 10 | Solitary fibrous tumor of the central nervous system: report of 2 cases and review of literature. | 2014 | 8 |
| 11 | 2017 | 2 | |
| 12 | 2013 | 1 |
About Chuang Lin
Chuang Lin is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rheumatology, having authored 12 papers that have together received 432 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (2 papers), Soft tissue tumor case studies (2 papers), Cellular Mechanics and Interactions (2 papers), Cancer-related molecular mechanisms research (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper), Nerve injury and regeneration (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (128 citations), Molecular Biology (221 citations), Oncology (69 citations), Cell Biology (32 citations) and Immunology (36 citations). Chuang Lin has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Liang Zhao, Rui Zhou, Kehong Zheng, Shibin Yang, Hui Wang, Xin Li, Weidong Li, Mingxin Pan, Zetao Chen and Xueqing Yao. Their work appears in journals such as Oncogene, Cell Death and Disease, Cell Reports, Diagnostic Pathology and EBioMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.